First, if SLC30A8 “human knockouts”—or individuals with homozygous or compound heterozygous loss of function mutations—were identified [18, 79], they could be deeply characterized for various phenotypes to better understand the intermediate human physiological processes responsible for T2D protection. Here, SLC30A8 is linked to type 2 diabetes mellitus.